What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Urology

PUBLISHER: TechNavio | PRODUCT CODE: 1743403

PUBLISHER: TechNavio | PRODUCT CODE: 1743403

Global Overactive Bladder Therapeutics Market 2025-2029

PUBLISHED: May 30, 2025

PAGES: 221 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The overactive bladder therapeutics market is forecasted to grow by USD 901.9 mn during 2024-2029, accelerating at a CAGR of 4% during the forecast period. The report on the overactive bladder therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by aging population, rising prevalence of oab, and expansion of healthcare infrastructure.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	3.8%
CAGR	4%
Incremental Value	$901.9 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's overactive bladder therapeutics market is segmented as below:

By Product

Anticholinergics
Beta-3 adrenergic agonists
Others

By Distribution Channel

Retail pharmacies
Hospital pharmacies
Online

By Disease Type

Idiopathic overactive bladder
Neurogenic overactive bladder

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the adoption of minimally invasive treatments as one of the prime reasons driving the overactive bladder therapeutics market growth during the next few years. Also, increasing focus on awareness campaigns and increasing number of clinical trials will lead to sizable demand in the market.

The report on the overactive bladder therapeutics market covers the following areas:

Overactive Bladder Therapeutics Market sizing
Overactive Bladder Therapeutics Market forecast
Overactive Bladder Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading overactive bladder therapeutics market vendors that include AbbVie Inc., Apotex Inc., Astellas Pharma Inc., Aurobindo Pharma Ltd., Axonics Inc., Dr Reddys Laboratories Ltd., Ferring BV, Imbrium Therapeutics L.P, Johnson and Johnson Services Inc., Lipella Pharmaceuticals Inc., Lupin Ltd., Medtronic Plc, Medytox, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc., Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the overactive bladder therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR43955

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Overactive Bladder Therapeutics Market 2019 - 2023
- Historic Market Size - Data Table on Global Overactive Bladder Therapeutics Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Disease Type segment analysis 2019 - 2023
- Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact Analysis of U.S. Tariffs on Global Overactive Bladder Therapeutics Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
8.3 Anticholinergics - Market size and forecast 2024-2029
- Chart on Anticholinergics - Market size and forecast 2024-2029 ($ million)
- Data Table on Anticholinergics - Market size and forecast 2024-2029 ($ million)
- Chart on Anticholinergics - Year-over-year growth 2024-2029 (%)
- Data Table on Anticholinergics - Year-over-year growth 2024-2029 (%)
8.4 Beta-3 adrenergic agonists - Market size and forecast 2024-2029
- Chart on Beta-3 adrenergic agonists - Market size and forecast 2024-2029 ($ million)
- Data Table on Beta-3 adrenergic agonists - Market size and forecast 2024-2029 ($ million)
- Chart on Beta-3 adrenergic agonists - Year-over-year growth 2024-2029 (%)
- Data Table on Beta-3 adrenergic agonists - Year-over-year growth 2024-2029 (%)
8.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Distribution Channel

9.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
9.3 Retail pharmacies - Market size and forecast 2024-2029
- Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
9.4 Hospital pharmacies - Market size and forecast 2024-2029
- Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
- Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
9.5 Online - Market size and forecast 2024-2029
- Chart on Online - Market size and forecast 2024-2029 ($ million)
- Data Table on Online - Market size and forecast 2024-2029 ($ million)
- Chart on Online - Year-over-year growth 2024-2029 (%)
- Data Table on Online - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Disease Type

10.1 Market segments
- Chart on Disease Type - Market share 2024-2029 (%)
- Data Table on Disease Type - Market share 2024-2029 (%)
10.2 Comparison by Disease Type
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
10.3 Idiopathic overactive bladder - Market size and forecast 2024-2029
- Chart on Idiopathic overactive bladder - Market size and forecast 2024-2029 ($ million)
- Data Table on Idiopathic overactive bladder - Market size and forecast 2024-2029 ($ million)
- Chart on Idiopathic overactive bladder - Year-over-year growth 2024-2029 (%)
- Data Table on Idiopathic overactive bladder - Year-over-year growth 2024-2029 (%)
10.4 Neurogenic overactive bladder - Market size and forecast 2024-2029
- Chart on Neurogenic overactive bladder - Market size and forecast 2024-2029 ($ million)
- Data Table on Neurogenic overactive bladder - Market size and forecast 2024-2029 ($ million)
- Chart on Neurogenic overactive bladder - Year-over-year growth 2024-2029 (%)
- Data Table on Neurogenic overactive bladder - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by Disease Type
- Market opportunity by Disease Type ($ million)
- Data Table on Market opportunity by Disease Type ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
15.5 Apotex Inc.
- Apotex Inc. - Overview
- Apotex Inc. - Product / Service
- Apotex Inc. - Key news
- Apotex Inc. - Key offerings
- SWOT
15.6 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
15.7 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
- SWOT
15.8 Axonics Inc.
- Axonics Inc. - Overview
- Axonics Inc. - Business segments
- Axonics Inc. - Key offerings
- Axonics Inc. - Segment focus
- SWOT
15.9 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
15.10 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
15.11 Lupin Ltd.
- Lupin Ltd. - Overview
- Lupin Ltd. - Business segments
- Lupin Ltd. - Key news
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Segment focus
- SWOT
15.12 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
15.13 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
15.14 Ono Pharmaceutical Co. Ltd.
- Ono Pharmaceutical Co. Ltd. - Overview
- Ono Pharmaceutical Co. Ltd. - Product / Service
- Ono Pharmaceutical Co. Ltd. - Key offerings
- SWOT
15.15 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.16 Sumitomo Pharma Co. Ltd.
- Sumitomo Pharma Co. Ltd. - Overview
- Sumitomo Pharma Co. Ltd. - Business segments
- Sumitomo Pharma Co. Ltd. - Key offerings
- Sumitomo Pharma Co. Ltd. - Segment focus
- SWOT
15.17 Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product / Service
- Sun Pharmaceutical Industries Ltd. - Key news
- Sun Pharmaceutical Industries Ltd. - Key offerings
- SWOT
15.18 Teva Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key news
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

Product Code: IRTNTR43955

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Overactive Bladder Therapeutics Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Product - Market share 2024-2029 (%)
Exhibits39: Data Table on Product - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Product
Exhibits41: Data Table on Comparison by Product
Exhibits42: Chart on Anticholinergics - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Anticholinergics - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Anticholinergics - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Anticholinergics - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Beta-3 adrenergic agonists - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Beta-3 adrenergic agonists - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Beta-3 adrenergic agonists - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Beta-3 adrenergic agonists - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits54: Market opportunity by Product ($ million)
Exhibits55: Data Table on Market opportunity by Product ($ million)
Exhibits56: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits57: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits58: Chart on Comparison by Distribution Channel
Exhibits59: Data Table on Comparison by Distribution Channel
Exhibits60: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits68: Chart on Online - Market size and forecast 2024-2029 ($ million)
Exhibits69: Data Table on Online - Market size and forecast 2024-2029 ($ million)
Exhibits70: Chart on Online - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Online - Year-over-year growth 2024-2029 (%)
Exhibits72: Market opportunity by Distribution Channel ($ million)
Exhibits73: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits74: Chart on Disease Type - Market share 2024-2029 (%)
Exhibits75: Data Table on Disease Type - Market share 2024-2029 (%)
Exhibits76: Chart on Comparison by Disease Type
Exhibits77: Data Table on Comparison by Disease Type
Exhibits78: Chart on Idiopathic overactive bladder - Market size and forecast 2024-2029 ($ million)
Exhibits79: Data Table on Idiopathic overactive bladder - Market size and forecast 2024-2029 ($ million)
Exhibits80: Chart on Idiopathic overactive bladder - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Idiopathic overactive bladder - Year-over-year growth 2024-2029 (%)
Exhibits82: Chart on Neurogenic overactive bladder - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Neurogenic overactive bladder - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Neurogenic overactive bladder - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Neurogenic overactive bladder - Year-over-year growth 2024-2029 (%)
Exhibits86: Market opportunity by Disease Type ($ million)
Exhibits87: Data Table on Market opportunity by Disease Type ($ million)
Exhibits88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits89: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits90: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits91: Chart on Geographic comparison
Exhibits92: Data Table on Geographic comparison
Exhibits93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits149: Market opportunity By Geographical Landscape ($ million)
Exhibits150: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits151: Impact of drivers and challenges in 2024 and 2029
Exhibits152: Overview on criticality of inputs and factors of differentiation
Exhibits153: Overview on factors of disruption
Exhibits154: Impact of key risks on business
Exhibits155: Companies covered
Exhibits156: Company ranking index
Exhibits157: Matrix on companies position and classification
Exhibits158: AbbVie Inc. - Overview
Exhibits159: AbbVie Inc. - Product / Service
Exhibits160: AbbVie Inc. - Key news
Exhibits161: AbbVie Inc. - Key offerings
Exhibits162: SWOT
Exhibits163: Apotex Inc. - Overview
Exhibits164: Apotex Inc. - Product / Service
Exhibits165: Apotex Inc. - Key news
Exhibits166: Apotex Inc. - Key offerings
Exhibits167: SWOT
Exhibits168: Astellas Pharma Inc. - Overview
Exhibits169: Astellas Pharma Inc. - Product / Service
Exhibits170: Astellas Pharma Inc. - Key offerings
Exhibits171: SWOT
Exhibits172: Aurobindo Pharma Ltd. - Overview
Exhibits173: Aurobindo Pharma Ltd. - Product / Service
Exhibits174: Aurobindo Pharma Ltd. - Key offerings
Exhibits175: SWOT
Exhibits176: Axonics Inc. - Overview
Exhibits177: Axonics Inc. - Business segments
Exhibits178: Axonics Inc. - Key offerings
Exhibits179: Axonics Inc. - Segment focus
Exhibits180: SWOT
Exhibits181: Dr Reddys Laboratories Ltd. - Overview
Exhibits182: Dr Reddys Laboratories Ltd. - Business segments
Exhibits183: Dr Reddys Laboratories Ltd. - Key news
Exhibits184: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits185: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits186: SWOT
Exhibits187: Johnson and Johnson Services Inc. - Overview
Exhibits188: Johnson and Johnson Services Inc. - Business segments
Exhibits189: Johnson and Johnson Services Inc. - Key news
Exhibits190: Johnson and Johnson Services Inc. - Key offerings
Exhibits191: Johnson and Johnson Services Inc. - Segment focus
Exhibits192: SWOT
Exhibits193: Lupin Ltd. - Overview
Exhibits194: Lupin Ltd. - Business segments
Exhibits195: Lupin Ltd. - Key news
Exhibits196: Lupin Ltd. - Key offerings
Exhibits197: Lupin Ltd. - Segment focus
Exhibits198: SWOT
Exhibits199: Medtronic Plc - Overview
Exhibits200: Medtronic Plc - Business segments
Exhibits201: Medtronic Plc - Key news
Exhibits202: Medtronic Plc - Key offerings
Exhibits203: Medtronic Plc - Segment focus
Exhibits204: SWOT
Exhibits205: Merck and Co. Inc. - Overview
Exhibits206: Merck and Co. Inc. - Business segments
Exhibits207: Merck and Co. Inc. - Key news
Exhibits208: Merck and Co. Inc. - Key offerings
Exhibits209: Merck and Co. Inc. - Segment focus
Exhibits210: SWOT
Exhibits211: Ono Pharmaceutical Co. Ltd. - Overview
Exhibits212: Ono Pharmaceutical Co. Ltd. - Product / Service
Exhibits213: Ono Pharmaceutical Co. Ltd. - Key offerings
Exhibits214: SWOT
Exhibits215: Pfizer Inc. - Overview
Exhibits216: Pfizer Inc. - Product / Service
Exhibits217: Pfizer Inc. - Key news
Exhibits218: Pfizer Inc. - Key offerings
Exhibits219: SWOT
Exhibits220: Sumitomo Pharma Co. Ltd. - Overview
Exhibits221: Sumitomo Pharma Co. Ltd. - Business segments
Exhibits222: Sumitomo Pharma Co. Ltd. - Key offerings
Exhibits223: Sumitomo Pharma Co. Ltd. - Segment focus
Exhibits224: SWOT
Exhibits225: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits226: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits227: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits228: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits229: SWOT
Exhibits230: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits231: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits232: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits233: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits234: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits235: SWOT
Exhibits236: Inclusions checklist
Exhibits237: Exclusions checklist
Exhibits238: Currency conversion rates for US$
Exhibits239: Research methodology
Exhibits240: Information sources
Exhibits241: Data validation
Exhibits242: Validation techniques employed for market sizing
Exhibits243: Data synthesis
Exhibits244: 360 degree market analysis
Exhibits245: List of abbreviations